TY - BOOK AU - Ray,Charles E. AU - Gaba,Ron AU - Knuttinen,Martha-Gracia TI - Cholangiocarcinoma: diagnosis and treatment T2 - Cancer etiology, diagnosis, and treatments SN - 9781629480343 PY - 2015///] CY - New York PB - Nova Biomedical KW - Bile ducts KW - Cancer KW - Diagnosis KW - Treatment N1 - Includes bibliographical references and index; CHOLANGIOCARCINOMA: DIAGNOSIS AND TREATMENT; CHOLANGIOCARCINOMA: DIAGNOSIS AND TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Epidemiology of Cholangiocarcinoma; Introduction; Epidemiologic Data; Cholangiocarcinoma; Intrahepatic Cholangiocarcinoma (ICC) (Table 2); Extrahepatic Cholangiocarcinoma (ECC) (Table 2); Risk Factors for Cholangiocarcinoma; Liver Fluke Infection; Primary Sclerosing Cholangitis; Choledochal Cysts; Hepatolithiasis; Thorotrast Exposure; Chronic Hepatitis C; Chronic Hepatitis B; Other Risk Factors; Conclusion; References; Chapter 2: Pathology of CholangiocarcinomaIntroduction; Risk Factors; Disease Classification; Gross Morphology; Microscopic Features; Cytologic Characteristics; Staining Attributes; Conclusion; References; Chapter 3: Cholangiocarcinoma: A Clinical Perspective; Introduction; Types; Anatomic Classification; cHCC-CCA; Trends in Incidence and Demographics; General Trends; Mortality and Prognosis; Risk Factors; General; Precursor Lesions; Primary Sclerosing Cholangitis; Biliary Tract Cysts; Gallstone Disease; Liver Flukes; Viral Hepatitis; Stage of Liver Disease; Diabetes, Obesity, Diet, and Metabolic SyndromeAlcohol and Tobacco; Transplant of Non-Liver Organs; Toxins; Diagnosis; Clinical Features and Tumor Markers; Imaging and Invasive Diagnostic Modalities; Differential Diagnosis; Natural History; Screening; Screening in PSC Patients; Conclusion; References; Chapter 4: Imaging of Cholangiocarcinoma; Introduction; Anatomic Location of Cholangiocarcinoma; Intrahepatic Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Distal Cholangiocarcinoma; Morphologic Types of Cholangiocarcinoma; Periductal Infiltrating CholangiocarcinomaMass-Forming Cholangiocarcinoma; Intraductal Cholangiocarcinoma; Mucin Hypersecreting Biliary Intraductal Papillary Carcinoma; Imaging of Intrahepatic Cholangiocarcinoma; Ultrasound (US); Computed Tomography (CT); Magnetic Resonance (MR) Imaging; Imaging of Extrahepatic Cholangiocarcinoma; Findings in Determining Resectability; Imaging of Perihilar and Distal Cholangiocarcinoma; Ultrasound; Computed Tomography; Magnetic Resonance Imaging; Magnetic Resonance Cholangiopancreatography; Choledochal Cysts; Mimics of Cholangiocarcinoma; Differentiating Benign from Malignant StricturesMetastases; Primary Sclerosing Cholangitis; IgG4 Cholangitis; Conclusion; References; Chapter 5: Role of PET/CT in Diagnosis and Management of Cholangiocarcinoma; Basis of 18F- FDG-PET/CT; Clinical Impact of (18)FDG-PET; Primary Diagnosis; Lymph Nodes and Distant Metastases Detection; Therapeutic Response Evaluation; Potential Pitfalls (Figure 6); Investigational PET Imaging Modalities; References; Chapter 6: Surgical Treatment of Cholangiocarcinoma; Palliative Therapy; Surgical Resection; Limiting Factors to Resection N2 - Cholangiocarcinoma is a devastating illness with poor long-term survival. The diagnosis and treatment of cholangocarcinoma is becoming increasingly important, particularly with the increasing incidence of hepatocellular carcinoma, another primary liver tumor. Since the diagnosis, treatment, and prognosis of the two similar malignancies vary tremendously, a thorough understanding of cholangiocarcinoma is vital for any practitioner dealing with this patient population. The diagnosis and treatment of patients with this disease requires input from nearly every specialist in cancer care: pathologis UR - https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1023452 ER -